Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 62,175 | 14,638 | 0 | 0 | 0 |
| Cost of Goods | 2,152 | 636 | N/A | N/A | N/A |
| Gross Profit | 60,023 | 14,002 | N/A | N/A | N/A |
| Operating Expenses | 176,479 | 177,175 | 152,037 | 117,176 | 98,534 |
| Operating Income | -116,304 | -162,537 | -152,037 | -117,176 | -98,534 |
| Interest Expense | 3,679 | 3,656 | 3,838 | 3,971 | 3,504 |
| Other Income | 13,019 | 14,222 | 8,334 | 8,953 | 3,298 |
| Pre-tax Income | -106,964 | -151,971 | -147,541 | -112,194 | -98,740 |
| Net Income Continuous | -106,964 | -151,971 | -147,541 | -112,194 | -98,740 |
| Net Income | $-106,964 | $-151,971 | $-147,541 | $-112,194 | $-98,740 |
| EPS Basic Total Ops | -4.92 | -7.10 | -7.38 | -5.73 | -5.34 |
| EPS Basic Continuous Ops | -4.92 | -7.10 | -7.38 | -5.74 | -5.34 |
| EPS Diluted Total Ops | -4.92 | -7.10 | -7.38 | -5.73 | -5.34 |
| EPS Diluted Continuous Ops | -4.92 | -7.10 | -7.38 | -5.74 | -5.34 |
| EPS Diluted Before Non-Recurring Items | -4.92 | -7.10 | -7.38 | N/A | N/A |
| EBITDA(a) | $-115,984 | $-161,798 | $-151,214 | $-116,281 | $-97,725 |